Support for LAist comes from
Audience-funded nonprofit news
Stay Connected
Audience-funded nonprofit news
Listen
Podcasts Take Two
Amid growing opioid risk, pharma makes push to market OxyContin abroad
solid orange rectangular banner
()
Dec 19, 2016
Listen 8:03
Amid growing opioid risk, pharma makes push to market OxyContin abroad
Companies that make opioid drugs are looking overseas boost sales - and that's causing concern among medical officials.
With concern growing about the opioid addiction epidemic in the US, companies are pushing to market overseas, find a new L.A. Times investigation into OxyContin.
()

Companies that make opioid drugs are looking overseas boost sales - and that's causing concern among medical officials.

It's probably the most notorious prescription drug of our times – OxyContin.

Here in the US, because of widespread abuse and addiction, authorities are clamping down on it, and other opium-based painkillers. So the companies that make opioid drugs are looking overseas boost sales, and that's causing concern among medical officials.

The international push is coming from a group of companies, known as Mundipharma.

Los Angeles Times journalist Harriet Ryan spoke with A Martinez about her reporting.

To listen to the full interview, click on the blue media player above.